
Juliet Naomi Barker MD
Hematology/Oncology
Associate Professor, Medicine, Weill Cornell Medical College
Request Appointment
520 E 70th St# 341New York, NY 10021
Fax+1 212-746-6678
Overview of Dr. Barker
Dr. Juliet Barker is an internist in New York, NY and is affiliated with New York-Presbyterian Hospital. She received her medical degree from The University of Adelaide Faculty of Health Sciences and has been in practice 28 years. Dr. Barker accepts several types of health insurance, listed below. She is one of 1205 doctors at New York-Presbyterian Hospital who specialize in Internal Medicine. She has more than 100 publications and over 500 citings.
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 1996 - 1999
- The University of Adelaide Faculty of Health SciencesClass of 1989
Certifications & Licensure
- FL State Medical License 2021 - Present
- NY State Medical License 2004 - 2026
- NJ State Medical License 2021 - 2023
- MN State Medical License 1999 - 2005
Clinical Trials
- Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Start of enrollment: 2006 Jul 01
- Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Start of enrollment: 2006 Nov 28
- Adult Double Cord Blood Transplant Study Start of enrollment: 2007 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell Transplant.Stephen Eng, Grashma Vadakkel, Samantha Brown, Susan Murillo, Warren Fingrut
Transplantation and Cellular Therapy. 2025-07-09 - Bone marrow and blood demonstrate distinct immune reconstitution patterns and correlations with relapse post-transplant.Susan DeWolf, Jason Kuttiyara, Paola Vinci, Teng Fei, John Slingerland
Blood Advances. 2025-06-12 - 1 citationsPhase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation.Ioannis Politikos, Samantha Brown, Joshua A Fein, Stephen Eng, Kristian Casem
Blood Advances. 2025-05-27
Press Mentions
- Research Leaders Across New York State Form Empire State Cellular Therapy ConsortiumJuly 10th, 2025
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPOGreat West PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: